SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-284005
Filing Date
2019-11-05
Accepted
2019-11-05 07:00:55
Documents
3
Period of Report
2019-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d813727d8k.htm 8-K 18068
2 EX-99.1 d813727dex991.htm EX-99.1 86210
3 GRAPHIC g813727g1105034359937.jpg GRAPHIC 6698
  Complete submission text file 0001193125-19-284005.txt   114850
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 191191699
SIC: 2834 Pharmaceutical Preparations